Evidence map›Paper›PMID 34604064›Full record

ArticleFrontiers in oncology2021

Melanoma in Adolescents and Young Adults: Evaluation of the Characteristics, Treatment Strategies, and Prognostic Factors in a Monocentric Retrospective Study.

Paolo Del Fiore, Irene Russo, Beatrice Ferrazzi, Alessandro Dal Monico, Francesco Cavallin, Angela Filoni, Saveria Tropea, Francesco Russano, Claudia Di Prata, Alessandra Buja and 17 more

Erratum issuedAbstract read
In one paragraph

Article in Frontiers in oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

27 authors.

Paolo Del FioreSoft-Tissue, Peritoneum and Melanoma Surgical Oncology Unit, IOV- IRCCS, Padua, Italy.
Irene RussoSoft-Tissue, Peritoneum and Melanoma Surgical Oncology Unit, IOV- IRCCS, Padua, Italy.
Beatrice FerrazziPostgraduate School of Occupational Medicine, University of Verona, Verona, Italy.
Alessandro Dal MonicoDepartment of Medicine, University of Padua School of Medicine and Surgery, Padua, Italy.
Francesco CavallinIndependent Statistician, Solagna, Italy.
Angela FiloniSoft-Tissue, Peritoneum and Melanoma Surgical Oncology Unit, IOV- IRCCS, Padua, Italy.
Saveria TropeaSoft-Tissue, Peritoneum and Melanoma Surgical Oncology Unit, IOV- IRCCS, Padua, Italy.
Francesco RussanoSoft-Tissue, Peritoneum and Melanoma Surgical Oncology Unit, IOV- IRCCS, Padua, Italy.
Claudia Di PrataSoft-Tissue, Peritoneum and Melanoma Surgical Oncology Unit, IOV- IRCCS, Padua, Italy.
Alessandra BujaDepartment of Cardiological, Thoracic, Vascular Sciences and Public Health, University of Padua, Padua, Italy.
Alessandra CollodettoSoft-Tissue, Peritoneum and Melanoma Surgical Oncology Unit, IOV- IRCCS, Padua, Italy.
Romina SpinaSoft-Tissue, Peritoneum and Melanoma Surgical Oncology Unit, IOV- IRCCS, Padua, Italy.
Sabrina CarraroSoft-Tissue, Peritoneum and Melanoma Surgical Oncology Unit, IOV- IRCCS, Padua, Italy.
Rocco CappellessoPathological Anatomy Unit, University Hospital of Padua, Padua, Italy.
Lorenzo NicolèDepartment of Medicine (DIMED), Unit of Pathology & Cytopathology, University of Padua, Padua, Italy.
Vanna Chiarion-SileniMelanoma Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
Jacopo PigozzoMelanoma Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
Luigi Dall'OlmoSoft-Tissue, Peritoneum and Melanoma Surgical Oncology Unit, IOV- IRCCS, Padua, Italy.
Marco RastrelliSoft-Tissue, Peritoneum and Melanoma Surgical Oncology Unit, IOV- IRCCS, Padua, Italy.
Antonella VecchiatoDepartment of Surgery, Oncology and Gastroenterology (DISCOG), University of Padua, Padua, Italy.
Clara BennaDepartment of Surgery, Oncology and Gastroenterology (DISCOG), University of Padua, Padua, Italy.
Chiara MeninImmunology and Diagnostic Molecular Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
Daniela Di CarloHematology/Oncology Division, Department of Women's and Children's Health, University of Padua, Padua, Italy.
Gianni BisognoHematology/Oncology Division, Department of Women's and Children's Health, University of Padua, Padua, Italy.
Angelo Paolo Dei TosPathological Anatomy Unit, University Hospital of Padua, Padua, Italy.
Mauro AlaibacDivision of Dermatology, Department of Medicine (DIMED), University of Padua, Padua, Italy.
Simone MocellinSoft-Tissue, Peritoneum and Melanoma Surgical Oncology Unit, IOV- IRCCS, Padua, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The "Veneto Cancer Registry" records melanoma as the most common cancer diagnosed in males and the third common cancer in females under 50 years of age in the Veneto Region (Italy). While melanoma is rare in children, it has greater incidence in adolescents and young adults (AYA), but literature offers only few studies specifically focused on AYA melanoma. The aim of this study was to describe the characteristics, surgical treatment, and prognosis of a cohort of AYA melanoma in order to contribute to the investigation of this malignancy and provide better patient care. This retrospective cohort study included 2,752 Caucasian patients (702 AYA and 2,050 non-AYA patients) from the Veneto Region who were over 15 years of age at diagnosis, and who received diagnosis and/or treatment from our institutions between 1998 and 2014. Patients were divided in adolescents and youth (15-25 years), young adults (26-39 years) and adults (more than 39 years) for the analysis. We found statistically significant differences in gender, primary site, Breslow thickness, ulceration, pathologic TNM classification (pTNM) stage and tumor subtype among the age groups. Disease-specific survival and disease-free survival were also different among the age groups. Our findings suggest that the biological behavior of melanoma in young people is different to that in adults, but not such as to represent a distinct pathological entity. Additional and larger prospective studies should be performed to better evaluate potential biological and cancer-specific differences between AYAs and the adult melanoma population.

Indexed as

adolescent and young adult melanomaadolescent and young adult oncologyAYAincidencemelanomamelanoma surgical treatmentskin cancersurvival

Identifiers

PMID34604064
PMCPMC8482997

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.